PRINT  |
News Update Items
COVID-19 Guidelines at MHNI
The Michigan Headache & Neurological Institute (MHNI) continues its regular operations.
New Migraine Study
A new Migraine research study sponsored by Allergan is being conducted at MHNI.
Sphenopalatine Ganglion Blocks for Headache
MHNI has received a number of inquiries about the use of sphenopalatine ganglion (SPG) blocks for headache.
MHNI Featured on Today Show
NBC’s Today morning show featured Drs. Saper and Moheyuddin and a patient who came to MHNI for relief of her chronic migraines.
Dr. Saper, MHNI recognized as a Clinical Center of Excellence by the American Pain Society
Dr. Joel Saper accepted the American Pain Society Clinical Center of Excellence in Pain Management award on behalf of MHNI.
Temporomandibular Dysfunction and Headache
Temporomandibular joint (TMJ) pain is a known headache trigger. Fortunately, a suprising number of the factors that contribute to TMJ pain can be treated through physical therapy.
Exercise and Migraine Headache
So, your doctor has told you that it’s important to get regular exercise, both for maximizing your overall health, and for helping to manage your migraines. Are you skeptical? You’re not alone.
Neuromodulation Offers Hope for Chronic Headaches
Neurologist Joel Saper doesn't believe there's a panacea for chronic headache, but does offer hope in promising new treatments, including neuromodulation.
Dr. Joel Saper Named One of America’s Top Doctors for Women by Women’s Health Magazine
The November 2008 issue of Women’s Health magazine includes a list of the best doctors in the specialties most important to women. Dr. Saper is featured in the “Top Neurologists” category – the only Michigan doctor among the 16 that were named in that specialty.
